The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057 · cited 2×
“…performed using the X-ray crystal structure of human Shp2 (PDB identification code 2SHP) (Hof et al., 1998) using the GLIDE program (Grid-Based Ligand Docking from Energetics, as part of the FirstDiscovery Suite from Schrödinger, Inc., Portland, OR) (Friesner et al., 2004; Halgren et al., 2004).”
MethodMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,177
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886
Protein kinase Cα activates RAF-1 by direct phosphorylation
Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marmé, D., & Rapp, U. R. (1993) · Nature · doi:10.1038/364249a0 · Cited by 1,277
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249 · cited 3×
“Gab1-Shp2 interaction and Shp2 PTP activity are necessary for Erk1/2 activation by these growth factors (Cunnick et al., 2002; Neel et al., 2003).”
BackgroundTartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
Crystal Structure of the Tyrosine Phosphatase SHP-2
Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 985
Oncogenic mechanisms of the Helicobacter pylori CagA protein
Hatakeyama, M. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1433 · Cited by 752
Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains
Andersen, J. N., Mortensen, O. H., Peters, G. H., Drake, P. G., Iversen, L. F., Olsen, O. H., Jansen, P. G., Andersen, H. S., Tonks, N. K., & Møller, N. P. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7117-7136.2001 · Cited by 715
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
Zhang, Z.-Y. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.083001.144616 · Cited by 433
Inhibitors of Protein Tyrosine Phosphatases: Next‐Generation Drugs?
Bialy, L., & Waldmann, H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461517 · Cited by 420
The ‘Gab’ in signal transduction
Gu, H., & Neel, B. G. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00002-3 · Cited by 388
Diverse Biochemical Properties of Shp2 Mutants
Keilhack, H., David, F. S., McGregor, M., Cantley, L. C., & Neel, B. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504699200 · Cited by 298
Maroun, C. R., Naujokas, M. A., Holgado-Madruga, M., Wong, A. J., & Park, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8513-8525.2000 · Cited by 286
Mohi, M. G., Williams, I. R., Dearolf, C. R., Chan, G., Kutok, J. L., Cohen, S., Morgan, K., Boulton, C., Shigematsu, H., Keilhack, H., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.010 · Cited by 277
Kratz, C. P. (2005) · Blood · doi:10.1182/blood-2005-02-0531 · Cited by 267
Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling
Yamauchi, K., Milarski, K. L., Saltiel, A. R., & Pessin, J. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.664 · Cited by 263
Multiple Requirements for SHPTP2 in Epidermal Growth Factor-Mediated Cell Cycle Progression
Bennett, A. M., Hausdorff, S. F., O’Reilly, A. M., Freeman, R. M., & Neel, B. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1189 · Cited by 246
Suramin: a novel antineoplastic agent with multiple potential mechanisms of action.
Stein, C. (1993) · PubMed · Cited by 227
Carroll, M. P., & May, W. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42250-2 · Cited by 214
Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
Oka, T., Ouchida, M., Koyama, M., Ogama, Y., Takada, S., Nakatani, Y., Tanaka, T., Yoshino, T., Hayashi, K., Ohara, N., et al. (2002) · PubMed · Cited by 208
Fragale, A., Tartaglia, M., Wu, J., & Gelb, B. D. (2004) · Human Mutation · doi:10.1002/humu.20005 · Cited by 194
Self-citationNishida, K., & Hirano, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01396.x · Cited by 190
Shen, K., Keng, Y.-F., Wu, L., Guo, X.-L., Lawrence, D. S., & Zhang, Z.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106568200 · Cited by 183
Lazo, J. S., Nemoto, K., Pestell, K. E., Cooley, K., Southwick, E. C., Mitchell, D. A., Furey, W., Gussio, R., Zaharevitz, D. W., Joo, B., et al. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12321-8 · Cited by 182
Crystal Structure of Human Protein-tyrosine Phosphatase SHP-1
Yang, J., Liu, L., He, D., Song, X., Liang, X., Zhao, Z. J., & Zhou, G. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210430200 · Cited by 173
Ren, Y., Meng, S., Mei, L., Zhao, Z. J., Jove, R., & Wu, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312575200 · Cited by 171
Self-citationCunnick, J. M., Mei, L., Doupnik, C. A., & Wu, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010275200 · Cited by 164
Self-citationRegulation of the Mitogen-activated Protein Kinase Signaling Pathway by SHP2
Cunnick, J. M., Meng, S., Ren, Y., Desponts, C., Wang, H.-G., Djeu, J. Y., & Wu, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110547200 · Cited by 162
Self-citationFunctional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells
Schubbert, S., Lieuw, K. H., Rowe, S. L., Lee, C. M., Li, X., Loh, M. L., Clapp, D. W., & Shannon, K. (2005) · Blood · doi:10.1182/blood-2004-11-4207 · Cited by 159
Chan, R. J., Leedy, M. B., Munugalavadla, V., Voorhorst, C. S., Li, Y., Yu, M., & Kapur, R. (2005) · Blood · doi:10.1182/blood-2004-10-4002 · Cited by 156
Germ-line and somatic PTPN11 mutations in human disease
Tartaglia, M., & Gelb, B. D. (2005) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2005.03.001 · Cited by 156
Crystal Structure of the Catalytic Domain of Protein-tyrosine Phosphatase SHP-1
Yang, J. P., Liang, X., Niu, T., Meng, W., Zhao, Z. J., & Zhou, G. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28199 · Cited by 118
Structural Determinants of SHP-2 Function and Specificity in Xenopus Mesoderm Induction
O’Reilly, A. M., & Neel, B. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.161 · Cited by 116
Deb, T. B., Wong, L., Salomon, D. S., Zhou, G., Dixon, J. E., Gutkind, J. S., Thompson, S. A., & Johnson, G. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16643 · Cited by 93
Suramin Derivatives as Inhibitors and Activators of Protein-tyrosine Phosphatases
McCain, D. F., Wu, L., Nickel, P., Kassack, M. U., Kreimeyer, A., Gagliardi, A., Collins, D. C., & Zhang, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312488200 · Cited by 66
Reversible regulation of SHP‐1 tyrosine phosphatase activity by oxidation
Cunnick, J. M., Dorsey, J. F., Mei, L., & Wu, J. (1998) · IUBMB Life · doi:10.1002/iub.7510450506 · Cited by 60
Self-citationStructure-Based design and discovery of novel inhibitors of protein tyrosine phosphatases
Huang, P., Ramphal, J. Y., Wei, J. C., Liang, C., Jallal, B., McMahon, G., & Tang, C. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00039-7 · Cited by 57
Cited by
Immune Checkpoint Inhibitors: Basics and Challenges
Li, B., Chan, H. L., & Chen, P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170804143706 · Cited by 480
The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T Cells
Amarnath, S., Mangus, C. W., Wang, J. C. M., Wei, F., He, A., Kapoor, V., Foley, J. E., Massey, P. R., Felizardo, T. C., Riley, J. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003130 · Cited by 446
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Gianchecchi, E., Delfino, D. V., & Fierabracci, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.003 · Cited by 270
Protein Tyrosine Phosphatases as Drug Targets: Strategies and Challenges of Inhibitor Development
Barr, A. J. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.241 · Cited by 266
Systems-level interactions between insulin–EGF networks amplify mitogenic signaling
Borisov, N., Aksamitiene, E., Kiyatkin, A., Legewie, S., Berkhout, J., Maiwald, T., Kaimachnikov, N. P., Timmer, J., Hoek, J. B., & Kholodenko, B. N. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.19 · Cited by 222
Metadata
- Authors
- Chen, L., Sung, S.-S., Yip, M. L. R., Lawrence, H. R., Ren, Y., Guida, W. C., Sebti, S. M., Lawrence, N. J., & Wu, J.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 70
- Issue
- 2
- Pages
- 562-570
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2121539092
- Cited by
- 279
- References
- 40
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.